AM-Pharma recibe €47 millones de Cowen Healthcare y del European Investment Bank

31/03/2020 Nota de prensa AM-PHARMA RECIBE €47 MILLONES DE COWEN HEALTHCARE Y DEL EUROPEAN INVESTMENT BANK. • €23m [US$25.5m] equity provided mainly by US-based Cowen Healthcare Investments• €24m [US$26.5m] finance facility provided by the European Investment Bank (EIB)• Increased funding allows for finalization of all Marketing Authorization Application preparation activities• Ysios Capital participated in the…

Ysios Capital participa en la ronda de €116M ($133M) de su participada AM-Pharma

16/07/2019 Nota de prensa YSIOS CAPITAL PARTICIPA EN LA RONDA DE €116 MILLONES ($133 MILLONES) DE SU PARTICIPADA AM-PHARMA. AM-Pharma B.V. (‘AM-Pharma, the Company’), a clinical stage biopharmaceutical company, leading in the development of a treatment for acute kidney injury (AKI) with its innovative recombinant human Alkaline Phosphatase therapeutic (recAP) today announces that it has…